Anthony Giordano
Technik-/Wissenschafts-/F&E-Leiter bei JANONE INC.
Profil
Anthony Giordano was the founder of Message Pharmaceuticals, Inc. (1997) and TheraVasc, Inc. (2009), where he held the titles of Vice President-Research and President, Chief Executive Officer & Director, respectively.
He is also the founder of Cognition Therapeutics, Inc. Dr. Giordano's current jobs include President & Chief Executive Officer at NeuroTherapia, Inc. (2019-present), Chief Executive Officer & Director at Merand Pharmaceuticals, Inc. (current), and Chief Scientific Officer at JanOne, Inc. (2019-present).
Dr. Giordano's former jobs include President, Chief Executive Officer & Director at Sulfagenix, Inc. (2014-2017), Director-Experimental Therapeutics at Feist-Weiller Cancer Center, Senior Scientist at Abbott Laboratories, President at Nucleonics, Inc., Adjunct Professor at Case Western Reserve University, Assistant Dean at Louisiana State University, President at Alteris Therapeutics, Inc., and Chief Scientific Officer at Acceptys, Inc. Dr. Giordano received his doctorate degree from The Ohio State University in 1988.
Aktive Positionen von Anthony Giordano
| Unternehmen | Position | Beginn |
|---|---|---|
| JANONE INC. | Technik-/Wissenschafts-/F&E-Leiter | 03.12.2019 |
TheraVasc, Inc.
 TheraVasc, Inc. Pharmaceuticals: MajorHealth Technology TheraVasc, Inc. operates as a pharmaceutical company. It develops treatments for various chronic medical diseases and drugs for unserved vascular disease markets. The company was founded by Anthony Giordano, Christopher Kevil and James Douglas Boudreaux in 2008 and is headquartered in Cleveland, OH. | Gründer | 01.08.2009 |
Merand Pharmaceuticals, Inc.
 Merand Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Merand Pharmaceuticals, Inc. engages in the provision of therapeutic products. It is developing a novel microRNA therapeutic (MicroRNA93 or miR-93) to treat patients suffering from Peripheral Arterial Disease (PAD). The company was founded in 2018 and is headquartered in Charlottesville, VA. | Vorstandsvorsitzender | - |
NeuroTherapia, Inc.
 NeuroTherapia, Inc. Pharmaceuticals: MajorHealth Technology NeuroTherapia, Inc. discovers and develops new therapies for diseases with an underlying component of neuroinflammation. The company was founded by Mohamed Naguib Attala and Joseph F. Foss in 2015 and is headquartered in Cleveland, OH. | Vorstandsvorsitzender | 01.12.2019 |
Ehemalige bekannte Positionen von Anthony Giordano
| Unternehmen | Position | Ende |
|---|---|---|
Sulfagenix, Inc.
 Sulfagenix, Inc. BiotechnologyHealth Technology Sulfagenix, Inc. operates as a biotechnology company. It offers SG1002, a natural-occurring molecule and hydrogen sulfide for, which deficits have been shown to exist in various serious diseases, including cardiovascular disease, type II diabetes, cancer, hypertension, Alzheimer’s disease, asthma, and wound healing. The company was founded by David Lefer and Gabriel Gojon, Sr. in 2011 and is headquartered in Chesterland, OH. | Vorstandsvorsitzender | 01.08.2017 |
Message Pharmaceuticals, Inc.
 Message Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Message Pharmaceuticals, Inc. develops pharmaceutical drugs. It operates as research development company involved in RNA research and exploring other types of RNAs to look for RNA-binding proteins, especially to combat RNA viruses and to treat all major disease categories. Message Pharmaceuticals was founded in 2002 and is located in Malvern, PA | Gründer | 01.01.2008 |
| Feist-Weiller Cancer Center | Corporate Officer/Principal | - |
Case Western Reserve University
 Case Western Reserve University Other Consumer ServicesConsumer Services Case Western Reserve University provides educational services. It offers a variety of undergraduate degree courses and graduate and professional options such as arts and sciences, dentistry, engineering, law, management, medicine, nursing, social work, and more. The firm also offers dual-degree programs. The company was founded in 1826 and is headquartered in Cleveland, OH. | Corporate Officer/Principal | - |
| Louisiana State University | Corporate Officer/Principal | - |
Ausbildung von Anthony Giordano
| The Ohio State University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| COGNITION THERAPEUTICS, INC. | Health Technology |
| ABBOTT LABORATORIES | Health Technology |
| JANONE INC. | Industrial Services |
| Private Unternehmen | 9 |
|---|---|
Alteris Therapeutics, Inc.
 Alteris Therapeutics, Inc. BiotechnologyHealth Technology Alteris Therapeutics, Inc. develops therapeutic cancer vaccine products. It engages in engages in the discovery and development of therapeutics and vaccines based on alternative gene splice forms for the treatment of cancer. The company was founded by Donald M. O’Rourke and Albert Wong in 2002 and is headquartered in Philadelphia, PA. | Health Technology |
TheraVasc, Inc.
TheraVasc, Inc. Pharmaceuticals: MajorHealth Technology TheraVasc, Inc. operates as a pharmaceutical company. It develops treatments for various chronic medical diseases and drugs for unserved vascular disease markets. The company was founded by Anthony Giordano, Christopher Kevil and James Douglas Boudreaux in 2008 and is headquartered in Cleveland, OH. | Health Technology |
Message Pharmaceuticals, Inc.
Message Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Message Pharmaceuticals, Inc. develops pharmaceutical drugs. It operates as research development company involved in RNA research and exploring other types of RNAs to look for RNA-binding proteins, especially to combat RNA viruses and to treat all major disease categories. Message Pharmaceuticals was founded in 2002 and is located in Malvern, PA | Health Technology |
Acceptys, Inc.
 Acceptys, Inc. Pharmaceuticals: MajorHealth Technology Part of Patrys Ltd., Acceptys, Inc. develops natural antibody technologies for infectious disease applications. The company is based in Sparta, NJ. Acceptys was acquired by Patrys Ltd. on December 03, 2008 for $2 million. | Health Technology |
Nucleonics, Inc.
 Nucleonics, Inc. Pharmaceuticals: MajorHealth Technology Nucleonics, Inc. develops RNA interference-based therapeutics. It offers DNA vaccine programs. The company was founded in January 2001 and is headquartered in Horsham, PA. | Health Technology |
Sulfagenix, Inc.
Sulfagenix, Inc. BiotechnologyHealth Technology Sulfagenix, Inc. operates as a biotechnology company. It offers SG1002, a natural-occurring molecule and hydrogen sulfide for, which deficits have been shown to exist in various serious diseases, including cardiovascular disease, type II diabetes, cancer, hypertension, Alzheimer’s disease, asthma, and wound healing. The company was founded by David Lefer and Gabriel Gojon, Sr. in 2011 and is headquartered in Chesterland, OH. | Health Technology |
Merand Pharmaceuticals, Inc.
Merand Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Merand Pharmaceuticals, Inc. engages in the provision of therapeutic products. It is developing a novel microRNA therapeutic (MicroRNA93 or miR-93) to treat patients suffering from Peripheral Arterial Disease (PAD). The company was founded in 2018 and is headquartered in Charlottesville, VA. | Health Technology |
| Feist-Weiller Cancer Center | |
NeuroTherapia, Inc.
NeuroTherapia, Inc. Pharmaceuticals: MajorHealth Technology NeuroTherapia, Inc. discovers and develops new therapies for diseases with an underlying component of neuroinflammation. The company was founded by Mohamed Naguib Attala and Joseph F. Foss in 2015 and is headquartered in Cleveland, OH. | Health Technology |
